Additional Information
Market: NYSE
Sector: Chemicals
Latest Price: 49.26  (1.88% Ascending)
52-week High: 80.50
52-week Low: 47.32
Market Cap: 44,572.30M
1 year chart
1 day chart

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 90 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

DuPont reports $1 bln share buyback, 2012 earnings at the high end of forecasts

12th Dec 2012, 9:16 am by Deborah Bacal
The $1 bln buyback, expected to be completed next year, is subject to receiving the proceeds from the sale of its perfomance coatings unit. The $1 bln buyback, expected to be completed next year, is subject to receiving the proceeds from the sale of its perfomance coatings unit.

Shares in chemicals maker DuPont (NYSE:DD) were up before the bell Wednesday after the company last night authorized a $1 billion share buyback program and said 2012 earnings will come in at the high end of forecasts.  

The buyback, expected to be completed next year, is subject to receiving the proceeds from the sale of its perfomance coatings unit. 

The company also updated its 2012 earnings outlook to be at the high end of the previous range of $3.25 to $3.30 per share, excluding items. 

Chair and CEO, Ellen Kullman, said: "Our fourth quarter performance is as expected and at the high end of our previous guidance.  I am pleased that our board authorized a significant stock repurchase program.  This program reflects our confidence in the underlying fundamentals of our business as well as our commitment to deliver value to our shareholders.  

"The buyback delivers meaningful near-term value with the remaining proceeds from the divestiture providing us the ability to further strengthen our balance sheet, preserving our flexibility to invest in selective growth opportunities."

DuPont also announced its outlook for 2013 earnings, which it expects will grow low-to-mid single digits, with sales rising in the low-single digits. 

The forecast is based on the view that all of its segments will have solid earnings growth compared to 2012, except performance chemicals, which is expected to be down "substantially", with margins declining six to seven percentage points in 2013. 

"While we are seeing indications that market conditions are firming up in some areas, volatility and uncertainty also persist," said Kullman.  "Our current outlook calls for our 2013 earnings to grow low- to mid-single digits over 2012 as the investments we are making in agriculture and nutrition, industrial biosciences and advanced materials continue to deliver results offset by the weakness in titanium dioxide markets.  

"We will provide more specific guidance with our fourth quarter earnings report."

In October, DuPont said that it would shed 1,500 jobs and take other steps to increase competitiveness after third-quarter earnings fell sharply. The restructuring plan will deliver pretax cost savings of about $450 million by eliminating costs supporting the performance coatings unit and taking additional steps to improve competitiveness. The plan also includes eliminating about 1,500 positions globally over in the next 12 to 18 months.

Shares in the chemicals maker rose 2.7 per cent prior to market open, to $44.87. 

No investment advice

Proactive Investors North America Inc, trades as "Proactiveinvestors USA & Canada".

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

You understand that we may be providing advertising and/or marketing services to companies mentioned on the site. A full list of companies that are paying for services from us, or our affiliated companies in the UK and Australia can be viewed here